N2-Trityl Olmesartan Acid CAS 752179-89-8 Purity >98,0% (HPLC) Olmesartan Medoxomil Intermediate Factory
Pasokan Kimia Ruifu Olmesartan Medoxomil Perantara Kalayan Kualitas Luhur:
4,5-Dimétil-1,3-Dioxol-2-Hiji (DMDO) CAS 37830-90-3
4-Klorométil-5-Metil-1,3-Dioxol-2-Hiji (DMDO-Cl) CAS 80841-78-7
Étil 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
Dietil 2-Propil-1H-Imidazole-4,5-Dikarboksilat CAS 144689-94-1
Trityl Olmesartan Étil Éster CAS 144690-33-5
Trityl Olmesartan Asam CAS 761404-85-7
N2-Trityl Olmesartan Asam CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Ngaran Kimia | N2-Trityl Olmesartan Asam |
sinonim | Asam Tritil Olmesartan (N2);Olmesartan N2-Trityl Impurity;4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ] métil] -1H-Imidazole-5-Asam Karboksilat;4-(2-Hydroxypropan-2-yl) -2-Propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) métil) -1H-Imidazole-5-Asam Karboksilat |
Nomer CAS | 752179-89-8 |
Nomer CAT | RF-PI1876 |
Status Saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C43H40N6O3 |
Beurat Molekul | 688.82 |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bodas ka Pareum-Bodas Bubuk |
Purity / Métode Analisis | > 98,0% (HPLC) |
Leungitna dina Drying | <1,00% |
Résidu on Ignition | <0,50% |
Najis Tunggal | <1,00% |
Total Kotoran | <2.00% |
Logam beurat (sakumaha Pb) | <20ppm |
Standar tés | Standar Perusahaan |
Pamakéan | Panganteur Olmesartan Medoxomil (CAS: 144689-63-4) |
Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap
N2-Trityl Olmesartan Acid (CAS: 752179-89-8) mangrupikeun perantara dina sintésis Olmesartan Medoxomil (CAS: 144689-63-4) sanyawa anu aya hubunganana.Olmesartan Medoxomil mangrupikeun antagonis reséptor angiotensin II anu parantos dianggo pikeun pengobatan tekanan darah tinggi.Olmesartan Medoxomil mangrupikeun prodrug Olmesartan, mangrupikeun inhibitor reséptor tipe 1 angiotensin II (AT1) anu ngahambat umpan balik pangaturan négatip ngeunaan sékrési renin, ngirangan sékrési aldosteron sareng nyababkeun panurunan résistansi vaskular periferal (vasodilation).Sanyawa ieu nunjukkeun kagiatan antihipertensi, cardioprotective, vasodilator, sareng anti radang.Olmesartan Medoxomil tiasa dianggo nyalira atanapi digabungkeun sareng agén antihipertensi sanés.Dina studi klinis komparatif dina pasien kalayan hipertensi penting, Olmesartan ngirangan tekanan darah diastolik linggih sacara signifikan tibatan Losartan, Valdesartan sareng Ibesartan, sedengkeun pangurangan tekanan darah sistolik sami pikeun sadaya pangobatan.